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Abstract
Background: Pollutant particles containing environmentally persistent free radicals (EPFRs) are formed during many
combustion processes (e.g. thermal remediation of hazardous wastes, diesel/gasoline combustion, wood smoke, cigarette
smoke, etc.). Our previous studies demonstrated that acute exposure to EPFRs results in dendritic cell maturation
and Th17-biased pulmonary immune responses. Further, in a mouse model of asthma, these responses were
enhanced suggesting exposure to EPFRs as a risk factor for the development and/or exacerbation of asthma.
The aryl hydrocarbon receptor (AHR) has been shown to play a role in the differentiation of Th17 cells. In the
current study, we determined whether exposure to EPFRs results in Th17 polarization in an AHR dependent manner.
Results: Exposure to EPFRs resulted in Th17 and IL17A dependent pulmonary immune responses including airway
neutrophilia. EPFR exposure caused a significant increase in pulmonary Th17 cytokines such as IL6, IL17A, IL22, IL1β, KC,
MCP-1, IL31 and IL33. To understand the role of AHR activation in EPFR-induced Th17 inflammation, A549 epithelial
cells and mouse bone marrow-derived dendritic cells (BMDCs) were exposed to EPFRs and expression of Cyp1a1 and
Cyp1b1, markers for AHR activation, was measured. A significant increase in Cyp1a1 and Cyp1b1 gene expression was
observed in pulmonary epithelial cells and BMDCs in an oxidative stress and AHR dependent manner. Further, in vivo
exposure of mice to EPFRs resulted in oxidative stress and increased Cyp1a1 and Cyp1b1 pulmonary gene expression.
To further confirm the role of AHR activation in pulmonary Th17 immune responses, mice were exposed to EPFRs in
the presence or absence of AHR antagonist. EPFR exposure resulted in a significant increase in pulmonary
Th17 cells and neutrophilic inflammation, whereas a significant decrease in the percentage of Th17 cells and
neutrophilic inflammation was observed in mice treated with AHR antagonist.
Conclusion: Exposure to EPFRs results in AHR activation and induction of Cyp1a1 and in vitro this is dependent on
oxidative stress. Further, our in vivo studies demonstrated a role for AHR in EPFR-induced pulmonary Th17 responses
including neutrophilic inflammation.
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Background
Combustion of hazardous waste and biofuels produces
many atmospheric pollutants including reactive trace
gases, polycyclic aromatic hydrocarbons, and particulate
matter (PM) [1, 2]. It is estimated that about 40–70% PM
is attributed to emissions from combustion and thermal re-
mediation sources [3]. Several epidemiological studies have
provided substantial evidence that long-term exposure to
PM contribute to the development of asthma and aggra-
vate existing asthma symptoms [4–6]. Although several
studies including our own studies have demonstrated an
association between exposure to PM derived from com-
bustion sources and exacerbation of asthma and respira-
tory tract infections [7, 8], very limited data exists about
the underlying mechanisms of their toxicity and the deteri-
orating effects leading to the development of respiratory
diseases as a result of their complexity and non-uniformity
in composition. Recent studies have identified environ-
mentally persistent free radicals (EPFRs) in PM from a var-
iety of combustion sources including thermal remediation
of hazardous wastes, diesel/gasoline combustion, wood
smoke, cigarette smoke, etc. [9–14]. In the current study,
we utilized an EPFR-containing ultrafine pollutant particle
system that was created by exposure of PM surrogates
(CuO on silica substrate) to 2-monochlorophenol vapors
at 230 °C (MCP230) [15, 16]. This procedure has been
shown to mimic the formation of EPFRs in the cooling
zone of combustion systems. It represents the chlorinated
phenol containing surface stabilized semi-quinone type free
radical emitted as the effluent from a variety of combustion
sources including biomass fuels, fossil fuels, and hazardous
materials where chlorinated hydrocarbons and Cu(II)O are
typically present [16, 17].
Our previous studies demonstrated that acute exposure
of mice to EPFRs resulted in cytotoxicity, pulmonary oxi-
dative stress, and lung dysfunction [8, 15]. Lung dysfunc-
tion correlated with increased maturation of dendritic
cells and a Th17-biased immunophenotype in the lungs,
however the mechanism of these responses was not com-
pletely understood. IL17A and Th17 cells have been
shown to play an important role in the pathophysiology of
airway diseases such as asthma and COPD [18, 19]. Cellu-
lar infiltration involving neutrophils and eosinophils is a
characteristic feature of chronic inflammatory diseases
[20]. Further, exaggerated neutrophilic inflammation and
Th17 immune responses are hallmarks of severe asthma
and are implicated in the development and promotion of
steroid-resistant asthma [18, 21–23]. Th17 effector cyto-
kines such as IL17A recruit neutrophils into the airway
[24, 25]. These data warranted the investigation of under-
lying molecular pathways leading to EPFR-induced IL17A
and Th17 responses.
Aryl hydrocarbon receptor (AHR) is a ubiquitous
ligand-dependent transcription factor [26]. AHR binds
to a wide array of exogenous and endogenous ligands
resulting in the induction of xenobiotic metabolizing en-
zymes. Several researchers have demonstrated induction
of cytochrome P450 metabolizing enzymes such as
Cyp1A1 as a result of environmental exposure to known
AHR ligands such as 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD). The levels of AHR and its activity are modu-
lated by exposure to its ligands [27]. Recent studies on
AHR have implicated them in induction of various cyto-
kines and chemokines and have demonstrated the role
of AHR in regulating the differentiation of Th17 cells
and production of Th17 cytokines such as IL17A and
IL22 [28]. Depending on the type of ligand, activation of
AHR can cause either Th17 or regulatory T cell differen-
tiation leading to exacerbation of inflammation or im-
munosuppression, respectively [29–31]. The role of
AHR in PM-induced pulmonary Th17 inflammation has
not been well studied.
In the current study, we determined the mechanism
underlying EPFR-induced Th17 inflammation. We demon-
strated that Th17 cells are essential for EPFR-induced pul-
monary neutrophilic inflammation and cytokine response.
Further, we demonstrated that exposure to EPFRs results
in AHR activation, as evidenced by increased expression of
AHR dependent genes Cyp1a1 and Cyp1b1, which is
dependent on EPFR-induced oxidative stress and cellular
uptake of the particles. Inhibition of AHR nuclear trans-
location and DNA binding abated EPFR-induced pulmon-
ary Th17 immune responses and associated neutrophilic
inflammation. Thus, EPFR-induced Th17 inflammatory re-
sponses are dependent on AHR activation.
Methods
Animals
Male and female C57BL/6 mice (age 8–10 weeks) were
purchased from Harlan (Indianapolis, IN). Male Ahr
knockout (Ahr−/−; B6.129-Ahrtm1Gonz/Nci) mice (age
16 weeks) were obtained from National Cancer Institute
(Frederick, MD). The IL17Ra−/− (Il17ratm1Koll) and
IL23p19−/− (Il23atm1Lex) on C57BL/6 background were
obtained from Amgen Inc. and Taconic, respectively. Both
male and female mice (age 8–10 weeks) were used for
experiments involving IL17Ra−/− and IL23p19−/− mice. All
mice were given free access to rodent chow and water ad
libitum and were maintained under controlled conditions
with 12 h light/dark cycle, temperature, humidity, and
specific pathogen free conditions. All animal protocols
were prepared according to the Guide for the Care and
Use of Laboratory Animals, and were approved by the
Institutional Animal Care and Use Committee at the
University of Tennessee Health Science Center and
Louisiana State University Health Sciences Center. Time-
points were chosen to capture peak antigen presenting cell
(hours) and Th cell responses (generally peak within a
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week after initial antigen stimulation) and reduce animal
numbers needed to observe these responses.
Exposure to PM and treatment with AHR antagonist
Radical containing ultrafine PM with mean aerodynamic
diameter of approximately 0.2 μm was previously char-
acterized by our colleague Dr. Slawo Lomnicki at the
Louisiana State University as described earlier [16].
MCP230 particles were suspended in sterile saline con-
taining 0.02% tween 80 (particle solution) at 1 mg/mL
concentration. The resulting suspension was subjected
to probe sonication on ice to disperse the particles and
maintain a suspension free of particulate aggregates.
Mice received 50 μl of the resulting suspension via oro-
pharyngeal aspiration as described earlier [32]. Control
mice were administered 50 μl of particle solution (Ve-
hicle). Two hours prior to exposure to vehicle or
MCP230, AHR activation was blocked by treating mice
with 10 mg/kg dose (i.p.) of CH223191 (1-Methyl-N-[2-
methyl-4-[2-(2-methylphenyl) diazenyl] phenyl-1H-pyra-
zole-5-carboxamide) (Cayman Chemical, Ann Arbor,
MI), which was shown to be a selective antagonist of
AHR [33, 34]. Here after, CH223191 will be referred as
AHR antagonist.
Luciferase assay for AHR activation
A549 cells were transfected with both a DRE-luciferase
reporter for AHR activation and a Renilla luciferase re-
porter (Dual-Luciferase Reporter Assay System, Pro-
mega). After 24 h, the cells were exposed to 50 μg/cm2
particles or 50 nM TCDD with or without 100 μM
Trolox, an antioxidant. Four hours after exposure to
PM, firefly luciferase activity was measured as increase
in luminescence in the presence of luciferin. Renilla
luciferase activity, assessed as increase in luminescence
in the presence of coelenterazine, was used to normalize
the AHR activation data for differences in transfection
efficiencies and cell number.
Cyp1a1 and Cyp1b1 expression in vitro
Human lung epithelial cells (A549) were cultured in
growth medium consisting of DMEM, 10% heat-
inactivated fetal bovine serum (FBS) and 100 U-mg/mL
penicillin-streptomycin. Cells were plated at a density of
4 × 104 cells/cm2 in 6-well plates and incubated for 24 h
to achieve ~ 80–85% confluence. Treatment groups in-
cluded media-only control; vehicle control (2.7%
DMSO); antioxidant 10 mM N-tert-Butyl-α-phenylni-
trone (PBN); uptake blocker cocktail (2.5 μg/mL Filipin
III; 10 μg/mL chlorpromazine; 10 μM Wortmannin);
50 μg/cm2 MCP50 (non-EPFR-containing particles);
50 μg/cm2 MCP230; MCP230+PBN; MCP50+uptake
blocker cocktail; MCP230+uptake blocker cocktail. Cells
receiving both particles and PBN and/or uptake blocker
cocktail were pre-treated with PBN and/or uptake
blocker cocktail for one hour before exposure to parti-
cles as described previously [35]. Each group was done
in triplicate and cells were incubated for 4 h at 37 °C
and 5% CO2. At the end of incubation, supernatants
were collected and flash frozen in liquid nitrogen. Cells
were washed twice with ice-cold PBS, scraped off the
plate using a rubber policeman, pelleted and flash frozen
in liquid nitrogen and stored at − 80 °C.
Quantitative real time PCR
Total RNA was isolated using RNeasy Plus Mini Kit (Qia-
gen, Valencia, CA) following manufacturer’s instructions
and cDNA was synthesized using Superscript III First
Strand Synthesis Supermix as per manufacturer’s instruc-
tions (Life Technologies, Carlsbad, CA). 50 ng of cDNA
was mixed with Power SYBR Green PCR Master Mix and
qPCR was performed using Roche LightCycler 480, (Ap-
plied Biosystems, Foster City, CA). Primers sequences for
Cyp1a1 (Amplicon Length: 148; Forward: GAGGAGCTA
GACACAGTGATTG; Reverse: TGTCTCTTGTTGTGCT
GTGG); Cyp1b1 (Amplicon Length: 151; Forward: CAC
CAGGTATCCTGATGTGC; Reverse: AGGCACAAAGC
TGGAGAAG); Hprt1 (Amplicon Length: 181; Forward:
TGGCGTCGTGATTAGTGATG; Reverse: ACAGAGGG
CTACAATGTGATG). Il17a expression was determined
using TaqMan gene expression assay (Applied Biosys-
tems, Waltham, MA). Data are normalized for Hprt1
or Gapdh and plotted as relative gene expression
using ΔΔCt analysis.
Bronchoalveolar lavage fluid (BALF) cellularity
Mice were humanely euthanized, and a small incision was
made in the upper region of the trachea and an 18-gauge
cannula was inserted into the incision. 1 mL of BALF isola-
tion buffer (PBS containing 0.5% BSA) was slowly instilled
and removed from the lungs. Cells were counted and
20,000 cells were spun on to a glass slide using a cytospin.
The slides were air dried and subsequently stained with
Hema-3 staining kit (Fisher Scientific, Pittsburgh, PA) fol-
lowing supplier’s instructions. Differential cell counts were
determined based on the morphology and staining of the
cells by counting at least 300 cells per slide.
Establishment of mouse model of asthma
A mouse model of asthma using chicken egg white ov-
albumin (OVA) (Sigma-Aldrich, St. Louis, MO) was gen-
erated. Briefly, a mixture of 20 μg of OVA emulsified in
Imject Alum (Pierce, Rockford, IL) was prepared and
mice were sensitized by injecting with the mixture i.p.
on protocol days 0, and 14. MCP230 (50 μg) was admin-
istered to wild type and IL17Ra−/− OVA+MCP230 group
mice on protocol day 23. Subsequently, mice were
challenged with 1% OVA solution made in saline by
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inhalation exposure for 20 min on protocol days 24, 25,
and 26. Mice were euthanized on protocol day 28; BALF
was collected for differential cell count analysis and
lungs were collected for performing histopathological
assessment.
Lung histopathology and in situ hybridization
Mice were euthanized, lungs were isolated and inflated
with zinc-formalin fixative at 25 cm constant water pres-
sure and fixed for 24 h before they were transferred to
70% ethanol. The lungs were then dehydrated, embed-
ded in paraffin and sectioned to 4 μm thick sections and
stained with hematoxylin and eosin to visualize the in-
flammation. In situ hybridization for Cyp1a1 RNA was
performed as described earlier [36] using RNAscope 2.5
HD assay kit (Advanced Cell Diagnostics, Newark, CA)
on lung sections of mice exposed to vehicle or MCP230.
Representative images of lung sections were acquired
using EVOS FL Auto cell imaging system (Life Science
Technologies, Grand Island, NY). To quantify inflamma-
tion, ten random airway microscopy fields were captured
at 10× magnification on the Nikon Eclipse Ci-L (Nikon
Corporation, Tokyo, Japan). Area of inflammation was
quantified using ImageJ software (National Institutes of
Health, Bethesda, MD). Data are represented as the area
of inflammation surrounding airway and normalized to
the size of the respective airway.
Flow cytometry
Single cell suspension of the lung cells and flow cyto-
metric staining of cells was performed as described earl-
ier [7, 32]. Mice were euthanized; lungs were subjected
to retrograde vascular perfusion with Hank’s Balanced
Salt solution (HBSS) to remove excess red blood cells.
The isolated lungs were coarsely dissociated using an
Octodissociator (Miltenyi, Germany). The dissociated
lungs were incubated with collagenase I (Invitrogen, NY)
, and 150 ng/mL DNase I (Sigma Aldrich, MO) for
30 min in HBSS. Following incubation, the lungs were
further subjected to dissociation with Octodissociator to
reduce the remaining cell clumps to single cell suspen-
sion. Cells were strained through a 40 μm cell strainer
(BD Biosciences, CA). The resulting cell suspension was
treated with RBC lysis buffer to remove any residual
blood cells. Cells were incubated for five hours at 37 °C
with a stimulatory cocktail containing 5% heat-
inactivated fetal bovine serum, 500 ng/mL ionomycin,
5 ng/mL phorbol 12-myristate 13-acetate (PMA)
(Sigma-Aldrich), and a protein transport inhibitor (Gol-
giPlug, BD Biosciences) made in RPMI 1640 media. Cells
were stained with a Fixable live/dead dye eFluor 780
(eBiosciences, San Diego, CA) and were subsequently
fixed, permeabilized and stained for T cell and intracel-
lular cytokine markers using antibodies eFluor450-CD3
(eBiosciences, CA), PerCP-CD4 (BioLegend, CA), FITC-
CD8 (eBiosciences, CA), and PE-IFNγ (eBiosciences, CA),
PE-Cy7-IL4 (eBiosciences, CA), APC-IL17A (eBios-
ciences, CA). A total of 1.2 million cells/sample were ana-
lyzed by FACS Canto II (BD Biosciences) and dead cells
were excluded from analysis. Flow cytometry data was an-
alyzed using FlowJo Software v.10 (FLOWJO LLC, OR).
Cytokine analysis
Cytokine levels in homogenized lung supernatants were
determined using MILLIPLEX MAP Mouse Th17 cyto-
kine magnetic bead panel (Millipore, Billerica, MA)
using Luminex 200 system (Luminex Corporation). The
following cytokines were assayed: IL1β, IL6, IL17A,
IL17E, IL21, IL22, IL31, IL33, keratinocyte-derived che-
mokine (KC) and monocyte chemotactic protein (MCP-
1). Raw data were plotted against a standard curve using
a five-parameter logistic regression to derive the concen-
trations for unknown samples. Data presented exclude
numbers beyond the sensitivity of the assay.
Statistics
Data are presented as means ± SEM. Data are analyzed
by GraphPad Prism software (Version 6). ANOVA with
post hoc analysis was performed to determine the level
of difference between experimental groups. p < 0.05 was
considered as statistically different.
Results
EPFRs induce pulmonary Th17 immune responses
Our previous study demonstrated that acute exposure to
EPFRs results in Th17-biased pulmonary inflammation
with increased neutrophils [35]. IL23 serves as a survival
and maintenance factor for Th17 cells [37, 38] and pro-
motes Th17 differentiation [39, 40]. IL23p19−/− mice are
deficient in Th17 cells and, therefore, this mouse model
was used to confirm that Th17 cells mediate the
increase in lung IL17A and neutrophil recruitment upon
MCP230 exposure. We exposed wild type (WT) and
IL23p19−/− mice to either vehicle or MCP230 (EPFR).
Percent Th17 cells and Il17a expression were measured.
A schematic for the MCP230 exposure and analysis of
Th17 cells, Il17a expression and cell differential in BALF
at 5 days post-exposure (dpe) is presented in Fig. 1a. In
congruence with our previously published results, a sig-
nificant increase in the percent of pulmonary Th17 cells
was observed in WT mice exposed to MCP230 com-
pared to vehicle. On the contrary, MCP230-exposed
IL23p19−/− mice failed to show an increase in the
percent of pulmonary Th17 cells (Fig. 1b and c;
CD3+CD4+ cells double positive for IFNγ and IL4 or IL4
and IL17A were excluded while gating). A significant
increase in the expression of Il17a was observed in
MCP230-exposed WT mice compared to vehicle, but no
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difference was seen in IL23p19−/− mice (Fig. 1d),
suggesting that increased Il17a expression in MCP230-
exposed WT mice is Th17 dependent. Expression of
Il17f was less than that of Il17a and there was no
difference between MCP230-exposed WT mice
compared to vehicle or to MCP230-exposed IL23p19−/−
mice (Additional file 1: Figure S1).
To determine the role of Th17 cells in EPFR-induced pul-
monary neutrophilic inflammation, we performed differential
cell counts in WT and IL23p19−/− mice exposed to
either vehicle or MCP230. In WT mice, exposure to
MCP230 significantly increased the numbers of
lymphocytes and neutrophils compared to that in vehicle
control, whereas these numbers were significantly less in
MCP230-exposed IL23p19−/− mice compared to that in
MCP230-exposed WT mice (Fig. 1e). Exposure to
MCP230 in both WT and IL23p19−/− mice resulted in
increases in the total number of leukocytes and
Fig. 1 Exposure to MCP230 induces immune responses in the lung in Th17 dependent manner. (a) Schematic of MCP230 exposure protocol.
Mice were exposed to MCP230 (50 μg) by oropharyngeal aspiration on day 0 and BAL fluid (BALF) or whole-lungs were collected on day 5 post-exposure.
(b) T cell subsets were quantified using flow cytometry. Pulmonary T helper cell responses were measured after vehicle or MCP230 exposure in WT and
IL23p19−/− mice. PMA/ionomycin-stimulated lung cells were stained with surface (CD3, CD4, and CD8) and intracellular (IFNγ, IL4, and IL17A) antibodies for
Th1, Th2, and Th17 cells. (c) Representative pseudo color dot plots of CD4+ T cells gated for IFNγ, and IL17A in WT and IL23p19−/− mice. (d) The expression
of Il17a relative to Gapdh in whole-lung homogenates of WT and IL23p19−/− mice exposed to vehicle or MCP230 was determined using RT-qPCR. e
Differential cell count of BALF from vehicle or MCP230-exposed WT or IL23p19−/− mice. f Representative photomicrographs of BALF cells
collected from WT and IL23p19−/− mice exposed to vehicle or MCP230. Arrowheads represent the neutrophils (black) and lymphocytes (white). Data
represent mean ± SEM from 3 to 5 mice. ap < 0.05, compared to WT Vehicle group. bp < 0.05, compared to WT MCP230 group, one-way ANOVA with
Tukey’s multiple comparisons test
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macrophages compared to respective vehicle exposed
mice. The numbers of total leukocytes and macrophages
were comparable between WT and IL23p19−/− mice
following exposure to MCP230 (Fig. 1e). Representative
images of higher numbers of neutrophils and lymphocytes
(black and white arrowheads, respectively) in MCP230-
exposed WT mice compared to MCP230-exposed
IL23p19−/− mice are shown in Fig. 1f.
EPFRs induce pulmonary neutrophilic inflammation in an
IL17A-dependent manner
To demonstrate that MCP230 exacerbates asthma and
determine if MCP230-induced pulmonary neutrophilic
inflammation is dependent on IL17A, an OVA-induced
mouse model of asthma was developed in WT and IL17
receptor alpha knockout (IL17Ra−/−) mice. A schematic
for the development of the mouse model of asthma,
exposure to MCP230, and BALF and histopathology
assessment is presented in Fig. 2a. BALF was collected
for differential cell counts and pulmonary inflammation
was determined by hematoxylin and eosin staining of
lung sections obtained at 5 dpe. A significant increase in
the percentage of neutrophils was observed in WT mice
exposed to OVA and MCP230 (WT OVA+MCP230)
compared to WT OVA mice; however, the percentage of
neutrophils was significantly less in IL17Ra−/− OVA
+MCP230 mice compared to MCP230-exposed WT
mice (Fig. 2b). No difference in the percentage of neu-
trophils was observed in IL17Ra−/− OVA+MCP230 mice
compared to IL17Ra−/− OVA mice. The percentage of
eosinophils was significantly decreased in WT OVA
+MCP230 mice compared to WT OVA mice (Fig. 2b);
and there were no significant changes in the numbers of
macrophages and lymphocytes. Total numbers of cells are
shown in Additional file 2: Figure S2. Histopathological
analysis revealed inflammation in the peribronchiolar/
perivascular areas in lungs of WT OVA+MCP230 mice,
while such inflammation was absent or mild in IL17Ra−/−
OVA+MCP230 mice (Fig. 2c and d). Together, these
results suggest that MCP230-induced pulmonary
Fig. 2 IL17A mediates MCP230-exacerbated pulmonary neutrophilic inflammation in asthma. a Schematic representing the protocol followed to induce in-
flammation in a mouse model of asthma. WT and IL17Ra−/− mice were sensitized with OVA (Ovalbumin complexed to Imject Alum) on days 0 and 14.
Mice were exposed to either vehicle or MCP230 (50 μg) on protocol day 23 and challenged with OVA on days 24, 25, and 26. BALF or lungs were
collected on day 28. b Differential cell counts of BALF cells at 5 days post-exposure (i.e. day 28) from mice challenged with OVA and exposed to vehicle or
MCP230. Data are represented as percentage of total BALF cells. Data represent mean ± SEM from 4 to 5 mice. ap < 0.05, compared to WT OVA group. bp
< 0.05, compared to WT OVA+MCP230 group, one-way ANOVA with Holm-Sidak’s multiple comparisons test. c Representative photomicrographs of the
lungs of WT and IL17Ra−/− mice challenged with OVA and exposed to vehicle or MCP230. Arrowheads point to areas of peribronchiolar and perivascular
inflammation. d Quantification of area of inflammation (μm2) surrounding the airways. Data represent mean ± SEM from 4 to 5 mice. ap< 0.05, compared
to WT OVA group. bp< 0.05, compared to WT OVA+MCP230, one-way ANOVA with Tukey's multiple comparisons test
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neutrophilic inflammation in WT OVA+MCP230 mice is
dependent on IL17A.
Exposure to EPFRs induces activation of AHR
AHR binds to a wide array of exogenous ligands (e.g. air
pollutants) resulting in the induction of xenobiotic me-
tabolizing enzymes and cytokines. Depending on the
type of ligand, AHR regulates differentiation of Th17
cells and production of Th17 cytokines such as IL17A
and IL22 [28]. To understand the role of AHR in
MCP230-induced Th17 inflammation, we investigated
whether acute exposure to MCP230 activates the AHR
pathway. AHR activation was analyzed in vitro using a
dual luciferase reporter assay in MCP230-exposed A549
cells. MCP230 exposure caused a significant increase in
luciferase activity as measured by luminescence, indicat-
ing AHR activation in MCP230-treated cells compared
to that of MCP50 (PM containing the organic and par-
ticle but lacking the EPFR [16]) treated cells (Fig. 3a).
The increase in the luminescence was comparable to the
luminescence in TCDD-exposed cells, a known AHR
agonist. A significant reduction in AHR activation was
observed when MCP230-exposed cells were co-treated
with trolox, an antioxidant. However, such reduction
was not observed in TCDD exposed cells co-treated with
trolox. No significant increase in AHR activation was
observed in cells treated with non-EPFR-containing PM
(SiO2, CuO/SiO2, or MCP50) compared to transfection
only group. These observations demonstrate that EPFRs
are important for the activation of AHR.
Using in vitro and in vivo studies, we previously dem-
onstrated that MCP230 induces the maturation of DCs
and enhances the capacity of DCs to stimulate the
Fig. 3 MCP230 exposure activates aryl hydrocarbon receptor (AHR)
and increases the expression of Cyp1a1. (a) Activation of AHR as
measured using a dual AHR luciferase reporter assay in A549 cells.
A549 cells were exposed to MCP230 (50 μg/cm2) or TCDD (50 nM)
and simultaneously treated with or without trolox (antioxidant;
100 μM) for 4 h. In addition, AHR activation was assessed in cells
exposed to non-EPFR-containing particle controls such as SiO2, CuO/
SiO2, and MCP50 (50 μg/cm2). AHR promoter activity is expressed as
normalized luminescence using a Renilla reporter for internal
normalization. Data represent mean ± SEM from one of two
independent experiments, performed in triplicate. ap < 0.05,
compared to MCP50 group. bp < 0.05, compared to MCP230
group, one-way ANOVA with Dunnett’s multiple comparisons
test. (b) Activation of AHR as measured by Cyp1a1 and Cyp1b1
expression relative to Gapdh using RT-qPCR analysis in the bone
marrow-derived dendritic cells (BMDCs). BMDCs from WT and
Ahr−/− mice were exposed to various concentrations of MCP230
for 4 h. Data represent mean ± SEM from one of two independent
experiments, performed in duplicate. ap < 0.05, compared to WT (0 μg/
cm2) group. bp < 0.05, compared to WT (12.5 μg/cm2) group, one-way
ANOVA with Tukey’s multiple comparisons test
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proliferation and activation of T cells [35]. Recently, it
was reported that AHR activation also induces matur-
ation of DCs [41]. To assess the role of MCP230 to acti-
vate AHR in DCs cuing Th17 responses and subsequent
neutrophilia, we determined the expression of AHR reg-
ulated genes Cyp1a1 and Cyp1b1 in bone marrow-
derived dendritic cells (BMDCs) isolated from WT and
Ahr−/− mice. Treatment of BMDCs derived from WT
mice with MCP230 caused a dose-dependent increase in
the expression of Cyp1a1 with significant difference at
concentrations 12.5 and 25 μg/cm2 compared to vehicle
treated control cells (Fig. 3b). Also, a significant increase
in the expression of Cyp1b1 was observed with exposure
to MCP230 at same concentrations. In contrast, and as
expected, treatment of BMDCs isolated from Ahr−/−
mice with MCP230 at 12.5 μg/cm2 did not result in any
change in Cyp1a1 and Cyp1b1 expression compared to
respective vehicle treated control cells (Fig. 3b).
Together, these data indicate that exposure to MCP230
induces AHR activation.
EPFRs induce expression of Cyp1a1 and Cyp1b1 in vitro in
an uptake-dependent and oxidative stress-dependent
manner
Previously, we reported that blocking cellular uptake of
MCP230 or oxidative stress inhibits the MCP230-induced
T cell activation and proliferation [35]. Thus, uptake
of MCP230 particles or oxidative stress induced by
MCP230 particles is important for its immune-
modulating effects. To determine if uptake of MCP230
was necessary for the activation of AHR, we pretreated
A549 cells with an uptake blocker cocktail (UB) or anti-
oxidant PBN followed by exposure to MCP230 and mea-
sured the expression of Cyp1a1 and Cyp1b1. Exposure to
MCP230 significantly increased the expression of Cyp1a1
(> 40-fold) and pretreatment with UB or PBN partially
inhibited the effects of MCP230 on Cyp1a1 expression
(Fig. 4a). Expression of Cyp1b1 was also reduced in cells
treated with UB or PBN and exposed to MCP230. Al-
though, exposure to MCP50 caused a significant increase
in Cyp1b1 expression, treatment of cells with UB signifi-
cantly inhibited the expression of Cyp1b1 (Fig. 4b). These
results indicate that MCP230-induced AHR activation is
dependent on both particle uptake and the ability to in-
duce generation of reactive oxygen species (ROS).
Exposure to EPFRs induces Cyp1a1 and Cyp1b1
expression in an AHR-dependent manner
To determine if MCP230-induced expression of Cyp1a1
and Cyp1b1 was dependent on activation of AHR, we
exposed A549 cells to MCP230 in the presence or ab-
sence of CH223191, a selective AHR antagonist (AHR
anta) that inhibits AHR-dependent transcription even at
10 μmol concentration [34]. FICZ is a high affinity
ligand of AHR and it has been shown to enhance Th17
responses and exacerbate immune-mediated diseases in
several mouse models [28, 31, 42]. Since the effects of
MCP230 are similar to that of FICZ, we switched to
using FICZ as a positive control for AHR activation. Ex-
posure to MCP230 and FICZ caused a significant
Fig. 4 Exposure to MCP230 increases the expression of Cyp1a1 and
Cyp1b1 in an uptake- and oxidative stress-dependent manner. A549
cells were exposed to MCP230 (50 μg/cm2) and simultaneously treated
with an antioxidant (PBN; 10 mM) or an uptake blocker cocktail (UB) for
4 h. Cyp1a1 (a) and Cyp1b1 (b) expression relative to Hprt was determined
by RT-qPCR. Data represent mean± SEM from one of two independent
experiments, performed in triplicate. ap< 0.05, compared to Media group.
bp< 0.05, compared to MCP50 group. cp< 0.05, compared to MCP230
group. dp< 0.05, compared to MCP230+PBN group, one-way ANOVA with
Tukey’s multiple comparisons test
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increase in the expression of Cyp1a1 (Fig. 5a) and
Cyp1b1 (Fig. 5b) compared to media or vehicle (DMSO)
controls. Pretreatment of MCP230-exposed cells with
AHR antagonist significantly reduced the expression of
both Cyp1a1 and Cyp1b1 compared to that in cells ex-
posed to MCP230 alone. Similarly, FICZ-induced
Cyp1a1 and Cyp1b1 expression was also inhibited by
AHR antagonist, indicating an AHR dependent expres-
sion of these proteins. These results further corroborate
the data presented in Figs. 3 and 4 that demonstrate
MCP230-induced activation of AHR.
Acute exposure to EPFRs results in transient activation of
AHR in vivo
We investigated whether exposure to EPFRs result in
transient or persistent activation of AHR in vivo. WT
mice were exposed to vehicle or MCP230 (50 μg) via oro-
pharyngeal aspiration, lungs were isolated at 4 and 24 h
post-exposure, and expression of Cyp1a1 and Cyp1b1
genes was determined. Exposure to MCP230 resulted in a
significant increase in the expression of Cyp1a1 and
Cyp1b1 at 4 h post-exposure compared to vehicle treated
controls (Fig. 6a and b). At 24 h post-exposure, the ex-
pression of both Cyp1a1 and Cyp1b1 were reduced to that
of the vehicle treated control (Fig. 6a and b). These data
indicate that acute exposure to MCP230 results in tran-
sient, but significant, increases in AHR activity in the
lungs. To determine if AHR was activated in airway or
immune cells, in situ hybridization for Cyp1a1 mRNA
was performed in the lungs isolated at 4 h post-exposure
from mice exposed to vehicle or MCP230. A significant
increase in Cyp1a1 was observed in the lungs of the mice
exposed to MCP230 compared to vehicle control. An in-
crease in Cyp1a1 positive cells was observed in the airway
epithelium and in the parenchymal regions in the lungs of
MCP230-treated mice (Fig. 6c). The specific cell types in
which MCP230 induced Cyp1a1 were not identified.
Exposure to EPFRs induces Th17 cytokine response in the
lung
In a different study in our lab, we observed that AHR
activation is increased through to 12 h and returns to
baseline by 24 h (data not shown). To determine the ef-
fects of MCP230 exposure on immediate immune re-
sponses, we measured Th17 associated cytokines in the
lungs of MCP230-exposed mice at 12 h post-exposure
and 1 dpe. A total of 10 cytokines (IL1β, IL6, IL21,
IL17A, IL22, IL17E, KC, MCP-1, IL33 and IL31) were
assessed. Acute exposure to MCP230 significantly in-
creased the levels of Th17 polarizing cytokines IL1β and
IL6 at 1 dpe, with significantly higher levels of IL6 (ap-
proximately 45 fold increase) as early as 12 h post-
exposure (Table 1). Th17 effector cytokines IL17A and
IL22 significantly increased at 1 dpe in the lungs of
MCP230-exposed mice, but were not different at 12 h.
These results indicate that exposure to MCP230 induces
Fig. 5 MCP230-induced expression of Cyp1a1 and Cyp1b1 is dependent on AHR activation. A549 cells were treated with MCP230 (50 μg/cm2) or
AHR agonist (FICZ; 200 nM) in the presence or absence of AHR antagonist (CH223191; 10 μM) for 4 h. Cell pellets were collected and expression
of Cyp1a1 (a) and Cyp1b1 (b) relative to Hprt was determined using RT-qPCR analysis. Data represent mean ± SEM from one of two independent
experiments, performed in triplicate. ap < 0.05, compared to Media group. bp < 0.05, compared to MCP230 group. cp < 0.05, compared to FICZ group,
one-way ANOVA with Tukey’s multiple comparisons test
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a Th17 cell-biased environment in the lungs. We also
analyzed the chemokines KC and MCP-1 in the lungs of
MCP230-exposed mice. The levels of both KC and
MCP-1 were significantly elevated at 1 dpe, with signifi-
cantly higher levels of MCP-1 as early as 12 h. In
addition, we observed an increase in the levels of IL33 at
12 h and 1 dpe. In contrast to the IL33 levels, a reduc-
tion in the levels of IL31 was observed, which was sig-
nificant at 12 h. No significant changes in the levels of
IL17E and IL21 were observed in mice exposed to
MCP230 compared to vehicle control (Table 1).
EPFR-induced Th17 pulmonary immune response and
pulmonary neutrophilic inflammation are dependent on
AHR activation
Exposure to MCP230 resulted in a significant increase in
the percent of Th17 cells in the lungs of mice as shown in
Fig. 1b and previously [35]. Recent reports indicate that
AHR activation leads to Th17 cell differentiation thus
leading to exacerbation of the inflammatory responses
[29–31]. To investigate the role of AHR in the MCP230-
induced Th17 response, we inhibited AHR activation in
MCP230-exposed mice by treating them with AHR
Fig. 6 Acute exposure to MCP230 results in transient activation of AHR and increased expression of Cyp1a1 and Cyp1b1 in vivo. (a, b) WT mice
were exposed to vehicle or MCP230 (50 μg) and lungs were isolated at 4 and 24 h post-exposure. Expression of Cyp1a1 and Cyp1b1 relative to
Hprt was measured using RT-qPCR analysis. Data represent mean ± SEM from one of two independent experiments. ap < 0.05, compared to
Vehicle group. bp < 0.05, compared to 4 h group, one-way ANOVA with Tukey’s multiple comparisons test. (c) Representative photomicrographs
of lungs from WT mice exposed to vehicle or 50 μg MCP230. Lungs were isolated from mice at 4 h post-exposure and stained for Cyp1a1 RNA
using in situ hybridization. Top panel represents expression of Cyp1a1 in lung parenchyma and bottom panel represents expression of Cyp1a1 in
the airway epithelium. Arrowheads point at cells expressing Cyp1a1
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antagonist (MCP230+AHR anta) and measured pulmon-
ary T cell sub-populations using intracellular cytokine
staining. Exposure to MCP230 resulted in a significant in-
crease in Th17 cells (IL17A producing CD3+CD4+ cells)
in the lungs of mice exposed to MCP230 compared to
vehicle exposed control mice. Treatment with AHR
antagonist significantly reduced the percent of Th17
cells in the lungs of MCP230-exposed mice compared
to that in MCP230-exposed mice not treated with AHR
antagonist (Fig. 7a and b). There was no significant dif-
ference in Th17 numbers between vehicle exposed con-
trol group and AHR antagonist treated groups [i.e.
Vehicle vs Vehicle+AHR anta (p = 0.17) or MCP230
+AHR anta (p = 0.31)].
To determine the role of AHR in MCP230-induced
neutrophil recruitment, we analyzed the inflammatory
cells in airways (BALF) of mice pre-treated with AHR
antagonist and exposed to MCP230. The mice were
treated with AHR antagonist 2 h prior to MCP230
exposure to inhibit AHR activation (i.e. at 4 h post
MCP230 exposure). In accordance with the data pre-
sented in Fig. 1, exposure to MCP230 increased the
total number of leukocytes in the lungs, with signifi-
cant increase in the number of neutrophils and lym-
phocytes compared to that in vehicle control.
Pretreatment with AHR antagonist significantly atten-
uated these high numbers of total leukocytes, includ-
ing neutrophils and lymphocytes, in MCP230-exposed
mice (Fig. 7c). Together, these results suggest that
AHR activation is required for MCP230-induced pul-
monary Th17 response and recruitment of inflamma-
tory neutrophils in lungs.
Discussion
Several epidemiological studies have demonstrated associ-
ation between exposure to airborne PM and increased risk
to develop asthma and/or acute asthma exacerbations
[43–45]. Although an association between elevated levels
of PM and respiratory diseases exist, the underlying mech-
anisms of PM-induced asthma exacerbations are not com-
pletely understood. In this study, we utilized an EPFR-
containing combustion-derived PM, a common form of
PM found in the atmosphere, and present a unique mech-
anism that mediates the pulmonary immune responses as
a result of exposure. The data presented here demonstrate
that MCP230, an EPFR-containing PM, results in pulmon-
ary neutrophilia that is dependent on Th17 cells and
IL17A. Further, we demonstrate that AHR signaling is im-
portant for EPFR-induced Th17 adaptive immune re-
sponse and pulmonary neutrophilia.
Pulmonary neutrophilic inflammation is a major char-
acteristic of patients with severe asthma. Studies in
humans with asthma and animal models of asthma dem-
onstrate that neutrophils play an important role in the
pathogenesis of severe asthma [21, 46]. Further, IL17A
has been shown to play an important role in the severity
of human airway diseases, such as asthma and COPD
[47]. Airway inflammation in severe and persistent
asthma is associated with IL17A; and Th17 cells play a
critical role in the activation and recruitment of neutro-
phils [23]. Our previous studies have shown that expos-
ure to EPFRs results in maturation of dendritic cells and
Th17 biased cell responses that were associated with
neutrophilic inflammation [35]. However, the mechan-
ism of EPFR-induced Th17 inflammation and associated
neutrophilia was not completely understood. In the
current study, MCP230-exposure caused an early immune
response in the form of increased Th17 cytokines includ-
ing neutrophil chemo-attractants. Using IL23p19 knock-
out (IL23p19−/−; mice deficient in Th17 responses) and
IL17Ra knockout (IL17Ra−/−) mice models, we have
confirmed that activation of Th17 cells and IL17A are
essential for neutrophilic inflammation in the lungs upon
exposure to EPFRs.
AHR binds to a wide array of exogenous and endogen-
ous ligands, activating inflammatory responses in various
diseases [27]. AHR is known to play a role in increased
differentiation of Th17 cells [30, 31]. Th17 cell differenti-
ation subsequent to ligand-dependent activation of AHR
has also been observed in other models of autoimmune
diseases [29–31], which may lead to exacerbation of in-
flammation involving neutrophilia. To understand the role
of AHR in MCP230-induced Th17 inflammation, we in-
vestigated whether acute exposure to MCP230 activates
the AHR pathway. Our results showed that exposure to
EPFRs induced activation of AHR (Fig. 3) and was con-
firmed by increased expression of Cyp1a1 and Cyp1b1 in
Table 1 MCP230 exposure results in pulmonary Th17 associated
cytokine induction
MCP230
Cytokines 12 h 1 d
IL1β 1.446 ± 0.1729 1.691 ± 0.2082a
IL6 45.71 ± 8.457a 10.61 ± 3.177a
IL21 0.7346 ± 0.0256 1.034 ± 0.1367
IL17A 0.6526 ± 0.1302 6.096 ± 1.666a
IL22 0.9377 ± 0.0325 1.504 ± 0.158a
IL17E 0.7034 ± 0.0941 0.9023 ± 0.0322
KC 5.629 ± 1.54 p = 0.053 2.591 ± 0.4729a
MCP-1 6.337 ± 1.325a 6.825 ± 0.2238a
IL33 2.226 ± 0.1384a 2.716 ± 0.1907a
IL31 0.3472 ± 0.07782a 0.4988 ± 0.0489
Levels of Th17 cytokines were determined in the lung homogenates of WT
mice exposed to MCP230 at 12 h and 1 day post-exposure. Concentrations
(pg/mg of lung protein) of all cytokines were measured using multiplex assay.
Data are expressed as means ± SEM of fold change over Vehicle treated controls
from 4 to 5 mice. ap < 0.05 compared to vehicle control, unpaired t test
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lung cells in vitro (Figs. 3, 4 and 5) and in vivo (Fig. 6).
This EPFR-induced Cyp1a1 and Cyp1b1 expression was
inhibited by an AHR antagonist (Fig. 5). Previously, we re-
ported that EPFR-induced oxidative stress and cellular up-
take of MCP230 particles are important for its immune-
modulating effects [35]. Oxidative stress is known to pro-
mote the polarization of T cell differentiation towards Th2
phenotype [48]; however, the role of oxidative stress in po-
larizing the T cell differentiation towards Th17 phenotype
is not completely understood and in the literature there is
conflicting information on the induction of oxidative
stress as a result of AHR activation [49, 50]. Interestingly,
our data showed that using an antioxidant or an uptake
blocker significantly inhibited the EPFR-induced Cyp1a1
and Cyp1b1 expression (Fig. 5), suggesting a role of EPFR-
induced oxidative stress in AHR activation.
IL17 mediates the influx of neutrophils in the lungs in
an OVA-induced mouse model of asthma and inhibiting
IL17, using monoclonal antibodies, reduces the bron-
chial influx of neutrophils [51]. In addition, Th17 cells
can induce neutrophilia by directly releasing chemoat-
tractants for neutrophils [25]. We demonstrate that ex-
posure to EPFRs results in increased levels of Th17
inducing cytokines IL1β and IL6 levels at 1 dpe, with
significantly high levels of IL6 as early as 12 h post-
exposure. IL6 is an important regulator of balance be-
tween regulatory T cells and Th17 cells [52]. The levels
of IL33 were also higher at 12 h post-exposure and 1
dpe, which can directly stimulate mast cells to produce
IL1β and IL6, and enhance the Th17 response [53, 54].
Further, we observed increase in cytokines IL17A and an
increase in the levels of neutrophil chemo attractants
Fig. 7 MCP230-induced pulmonary Th17 immune response is dependent on AHR activation. WT mice were exposed to vehicle or MCP230
(50 μg) that were treated with or without AHR antagonist (CH223191; 10 mg/kg) 2 h prior to the exposure. Lungs or BALF were collected at 5
dpe. (a, b) Lungs were used to determine adaptive T cell responses. PMA/ionomycin-stimulated lung cells were stained with surface (CD3 and
CD4) and intracellular (IL17A) antibodies. T cell subsets were quantified using flow cytometry. Data are presented as percentage of IL17A+ cells
among CD3+CD4+ cells (a) and representative flow cytometry pseudo color dot plots of IL17A+CD4+ cells gated on CD3+ T cells (b). Data
represent mean ± SEM from 4 to 5 mice. ap < 0.05, compared to Vehicle group. bp < 0.05, compared to MCP230 group, one-way ANOVA with
Holm-Sidak’s multiple comparisons test. (c) BALF were used to assess differential cell counts by counting at least 300 cells/sample. Data represent
mean ± SEM from one of two independent experiments, 4 to 5 mice. ap < 0.05, compared to Vehicle group. bp < 0.05, compared to MCP230
group, one-way ANOVA with Dunnett’s multiple comparisons test
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KC and MCP-1 in the airways at 1 dpe. Although we ob-
served only a transient activation of AHR, such AHR ac-
tivation can drive cytokine induction that leads to Th17
biased responses. We observed EPFR-induced immune
responses in mice beginning at 12 h post-exposure that
persisted until 5 dpe. Further studies are required to
understand the role of AHR activation in early immune
response and its effects on subsequent adaptive Th17
response.
We present evidence that AHR activation is necessary
for EPFR-induced pulmonary immune responses. Treat-
ment with AHR antagonist resulted in suppression of
EPFR-induced pulmonary Th17 responses and the asso-
ciated neutrophilic inflammation. AHR is expressed at
high levels in Th17 cells compared to other T cell sub-
sets [28] and we observed a significant reduction of
EPFR-induced Th17 cells in mice pre-treated with AHR
antagonist.
Conclusions
We demonstrated that EPFRs associated with
combustion-derived PM result in pulmonary immune
response in the form of early Th17 cytokine expression
and subsequent pulmonary neutrophilic inflammation.
This EPFR-induced pulmonary neutrophilic inflamma-
tion was shown to be dependent on Th17 and IL17A.
Our in vitro data demonstrated that EPFR-induced AHR
activation is mediated to some extent by the ability of
particles to generate oxidative stress and required uptake
of EPFRs. Further, we demonstrated that EPFRs induce
AHR activation in vivo and inhibition of AHR activation
using selective AHR antagonist resulted in inhibition of
pulmonary Th17 inflammation and associated neutro-
philia. In summary, our data illustrate a unique mechan-
ism by which radical containing particulate matter
mediate pulmonary Th17 immune responses through
AHR. In addition to Th17 cells, other cells like γδ T
cells [55, 56] and NKT cells [57] can produce IL17A and
contribute to inflammation prior to the development of
adaptive Th17 responses. Although beyond the scope of
this paper, our future studies will investigate the role of
AHR activation in these cells. Using Th17−/− mouse
model would directly address the importance of Th17
cells in MCP230-exacerbated asthma severity; however,
this model was not available when our experiments were
performed. While AHR−/− mice were available at the
time of these studies, we chose not to use them, because
among other physiological issues (e.g. defects in fertility,
perinatal growth, liver size and function, closure, spleen
size), they have defects in peripheral lymphocytes [58],
which would be important in the inflammatory re-
sponses to MCP230. Generation of conditional and cell-
specific AHR−/− models will be helpful to confirm our
results, but beyond the scope of this manuscript.
Additional files
Additional file 1: Figure S1. Il17f expression relative to Gapdh in
whole-lung homogenates of WT and IL23p19−/− mice exposed to vehicle
or MCP230 was determined using TaqMan gene expression assay (Applied
Biosystems, Waltham, MA). Expression was determined at 5 dpe. Data
represent mean ± SEM from 3 to 5 mice. (TIF 148 kb)
Additional file 2: Figure S2. WT and IL17Ra−/− mice were sensitized
with OVA (ovalbumin complexed to Imject Alum) on days 0 and 14. Mice
were exposed to either vehicle or MCP230 (50 μg) on protocol day 23
and challenged with OVA on days 24, 25, and 26. BAL fluid or lungs were
collected on day 28. Differential cell counts of BALF cells at 5 dpe (i.e. day 28)
from mice challenged with OVA and exposed to vehicle or MCP230. Data are
presented as mean ± SEM of numbers of cells from 4 to 5 mice. (TIF 9277 kb)
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